Cleveland, Ohio

Resilience System


You are here

Global

For older patients, Paxlovid cuts COVID hospitalization, death risk and speeds symptom relief --two new studies

New findings from two studies have tied use of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) to a reduction in COVID-19 hospitalizations and death, as well as to faster resolution of symptoms and less use of healthcare resources.

Benefit seen only in older patients

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Analysis: Can one die from long COVID? The answer is not so simple

...

While long COVID is not usually immediately or directly life-threatening, it’s possible it could exacerbate existing conditions, and play a role in a person’s death in this way.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

COVID-19's impact on global flu patterns and evolution traced in new study

Seasonal influenza epidemics impose substantial burdens on health care systems and cause >5 million hospitalizations of adults each year. The current approach to influenza vaccine development requires comprehensive surveillance of circulating strains, which are constantly moving from continent to continent....

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Global
howdy folks
Page loaded in 2.242 seconds.